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Elizabeth Oti RN, BSc
Otterbein University, Westerville, Ohio

Introduction
The author chose to write about
hypertension because she takes care of
patients and family members with
hypertension on a frequent basis, and is
likely to face the challenge of managing
patients with hypertension (HTN) in her
future role as a nurse practitioner due to
the high prevalence of HTN among men
and women. Non-Hispanic black adults
have the highest prevalence (42.1%)
compared with white (28.0%), Hispanic
(26.0%), and Asian Americans (24.7%).
In 2010, high blood pressure contributed
to the death of more than 362,000
Americans. Hypertension is defined as a
systolic blood pressure (SBP) of 140
mmHg or higher and/or a diastolic blood
pressure (DBP) of 90mmHg or higher.
Hypertension is often referred to as a
“silent killer” because many people with
the disease are asymptomatic.

•

•

•

•

Signs and Symptoms
•

•
•

•

Hypertension is called the “silent
killer” because it has no warning
signs or symptoms (Centers for
Disease Control and Prevention
[CDC], 2014).
In rare cases, HTN can cause
symptoms like headaches or
vomiting (CDC, 2014).
HTN is often asymptomatic and
may remain unrecognized if at-risk
patients are not screened (Klemas
& Dowling, 2015, p. 18).
Blood pressure (BP) is the major
indicator of essential hypertension
(see figure 1), so it is important to
know how to take blood pressure.

Pathophysiology of Essential Hypertension
(See figure 2).

How to Take Blood
Pressure

•

•

Wait at least 5 minutes between
entry into the office and blood
pressure measurement (Siu,
2015, p. 779).
Use an appropriately sized arm
cuff, and placed the patient's arm
at the level of the right atrium
during measurement (Siu, 2015,
p. 779).
Measure blood pressure in both
arms to check for any difference
at least once; if a difference is
noted then any subsequent
readings should be taken from the
arm with the higher reading
(Potts, 2014, p. 148).
Understand that systolic blood
pressure is the pressure in the
artery during systole or when the
heart is contracting; diastolic
blood pressure is the pressure in
the arteries during diastole or
when the heart is relaxing and
filling with blood (Potts, 2014, p.
146).
Multiple measurements over time
have better positive predictive
value for hypertension than a
single measurement (Siu, 2015, p.
779).
In addition to office blood
pressure measurement,
ambulatory blood pressure
measurement (ABPM) and home
blood pressure measurement
(HBPM) may be used to confirm a
diagnosis of hypertension after
initial screening (Siu, 2015, p.
780).

•
•

•

•

•
•

•

The pathogenesis of HTN is multifactorial and develops from a complex
interaction of genetic and environmental factors (Majumder & Wu, 2015, p.
258).
Endothelial dysfunction, enhanced activation of sympathetic nervous
system (CNS), and structural abnormalities in resistance vessels play critical
roles in the development and progression of HTN, but physiologically, the
renin angiotensin system (RAS) is one of the important pathways for
regulating blood pressure and vascular tone in the human body (Majumder
& Wu, 2015, p. 258).
The RAS pathway is initiated in the kidney with the proteolytic conversion
of angiotensinogen (produced in the liver) to angiotensin I (Ang I) by renin
(produced in the kidney); Ang I is an inactive decapeptide which can be
converted into a vasoconstrictive octapeptide, Ang II, by the action of
angiotensin converting enzyme (Majumder & Wu, 2015, p. 258).
Effects of Ang II (Bostock-Cox, 2013, p. 534) include: Increased sympathetic
activity; tubular sodium (Na+) and chloride (Cl–) reabsorption and
potassium (K+) excretion (water retention); aldosterone secretion
(increasing water [H2O] retention); arteriolar vasoconstriction (increase in
blood pressure), and increased antidiuretic hormone (ADH) secretion from
the pituitary gland (increasing H20 absorption).
The actions propagated by Ang II result in an increased in blood pressure.
Though RAS is widespread in the body, the main source of renin is the
juxtaglomerular apparatus of the kidney, while that of angiotensin
converting enzyme (ACE) is abundantly present [on] cell surface of
endothelial cells, especially in the lungs (Majumder& Wu, 2015, p. 259).
The major stimuli for secretion of renin from the juxtaglomerular apparatus
include glomerular hypoperfusion, reduced sodium intake, and increased
activity of the sympathetic nervous system (Simões e Silva & Flynn, 2012, p.
1836).

Significance of
Pathophysiology
•

•

•
•

•

•

•

•

•

Risk Factors for
Hypertension
According to Klemas and Dowling
(2015, p. 18), the risk factors for HTN
include:
•
Diabetes.
•
Advanced age.
•
Being African American.
•
Smoking tobacco.
•
Excess alcohol consumption.
•
Sedentary lifestyle.
•
Consumption of diet high in
sodium and low in potassium.
Figure 1 (Bostock-Cox, 2013, p. 532):
Classification of blood pressure for adults.

Initiation of medication is based on the
level of HTN and the number of risk
factors that are present along with any
evidence of damage to organs, such as the
heart or kidneys (Potts, 2014, p. 147).
Pathological outcomes induced by
angiotensin II include myocardial
infarction (MI), heart failure, stroke, and
renal failure (Ferrari, 2013, p. 3).
HTN is the second leading cause of endstage renal disease (ESRD) after diabetes
(Mennuni et al., 2014, p. 74).
Research shows salt sensitivity is
disproportionately manifest in African
Americans; healthy African Americans
have been shown to have more, not less,
activation of the RAS system than Whites;
circulating aldosterone levels are also
higher in African Americans than in
Whites (Flack, Nasser, & Levy, 2011, p.
84).
Understanding the pathophysiology will
aid in the initiation of pharmacological
therapy in the management of HTN (see
figure 3).
In people under the age of 55, ACE
inhibitors—or angiotensin receptor
blockers (ARBs) if ACE inhibitors cause
coughing—are used as first-line drugs
(Bostock-Cox, 2013, p. 534).
In people over 55, calcium-channel
blockers (CCBs) such as amlodipine or
felodipine are recommended as first-line
treatment (Bostock-Cox, 2013, p. 534).
Untreated HTN leads to progressive endorgan damage such as the eye
(hypertensive retinopathy), kidneys (endstage renal failure), brain (cerebrovascular
accident), and heart (heart failure)
(Nadella & Howell, 2015, p. 276).
Understanding adverse drug reactions
(ADRs) can lead to a better patient
outcome. For example, ACE inhibitors may
lead to an increased amount of circulating
bradykinin, leading to coughing; if this
happens, angiotensin receptor blockers
(ARBs) may be used, as these do not affect
bradykinin levels (Bostock-Cox, 2013, p.
534).

Nursing Implications
•

•

•

•

•

•

Measure BP and ensure that blood
pressure is within normal ranges,
educate patients to modify
behaviors related to diet, physical
activity, smoking, weight loss,
stress, alcohol consumption, and
medication compliance.
The currently recommended
dietary strategies to lower BP
include reducing salt intake,
increasing potassium intake, weight
loss, moderation of alcohol
consumption, and adoption of
balanced and “heart-friendly”
dietary patterns, such as the wellestablished Dietary Approaches to
Stop Hypertension (DASH) diet
(Koliaki & Katsilambros, 2013, p.
402) – See figure 4.
When taking BP, nurses need to
understand and educate patients
about possible short-term factors
that may affect BP readings such as
physical activity, drugs (including
caffeine and nicotine), pain, stress,
and emotions (Siu, 2015, p. 780).
Nurses should pay close attention
to “white coat syndrome”. Isolated
clinic HTN in the medical setting
and in the presence of medical
personnel (known as "white coat"
hypertension) is well documented
(Siu, 2015, p. 780).
U.S. Preventive Services Task Force
(USPSTF) recommends
confirmation outside of the clinical
setting before a diagnosis of HTN is
made and treatment is started (Siu,
2015, p. 781).
Given the higher incidence of HTN
in populations with risk factors,
annual screening may be warranted
for persons aged 40 years or older,
African Americans of any age, and
persons who are overweight or
obese (Siu, 2015, p. 783).

Figure 2: Pathophysiology of essential hypertension.
Figure 3 (Bostock-Cox, 2013, p. 533).

Figure 4: DASH food pyramid.

Conclusion
The diagnosis of HTN is
complicated by the “white coat”
phenomenon; therefore, ABPM and
HBPM should be considered before a
definitive diagnosis is made. Though
pharmacological treatment is key to
lowering BP by altering peripheral
vascular resistance and cardiac
output, a holistic approach will
require both the use of
pharmacological intervention and
lifestyle modification. Healthcare
providers need to work in
partnership with their patients to
accomplish set goals. Hypertension
often last a lifetime, therefore,
keeping BP under control can lower
the risk for heart disease, stroke and
kidney failure.
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